FR2835433B1 - Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2 - Google Patents

Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2

Info

Publication number
FR2835433B1
FR2835433B1 FR0201190A FR0201190A FR2835433B1 FR 2835433 B1 FR2835433 B1 FR 2835433B1 FR 0201190 A FR0201190 A FR 0201190A FR 0201190 A FR0201190 A FR 0201190A FR 2835433 B1 FR2835433 B1 FR 2835433B1
Authority
FR
France
Prior art keywords
methhoxy
3acetic
chlorobenzoyl
acetylamino
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0201190A
Other languages
English (en)
Other versions
FR2835433A1 (fr
Inventor
Richard Solange Froissant
Carole Chapelier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RICHARD LAB M
Original Assignee
RICHARD LAB M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RICHARD LAB M filed Critical RICHARD LAB M
Priority to FR0201190A priority Critical patent/FR2835433B1/fr
Publication of FR2835433A1 publication Critical patent/FR2835433A1/fr
Application granted granted Critical
Publication of FR2835433B1 publication Critical patent/FR2835433B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0201190A 2002-02-01 2002-02-01 Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2 Expired - Fee Related FR2835433B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0201190A FR2835433B1 (fr) 2002-02-01 2002-02-01 Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0201190A FR2835433B1 (fr) 2002-02-01 2002-02-01 Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2

Publications (2)

Publication Number Publication Date
FR2835433A1 FR2835433A1 (fr) 2003-08-08
FR2835433B1 true FR2835433B1 (fr) 2006-02-17

Family

ID=27619807

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0201190A Expired - Fee Related FR2835433B1 (fr) 2002-02-01 2002-02-01 Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2

Country Status (1)

Country Link
FR (1) FR2835433B1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
US8575217B2 (en) 2009-03-16 2013-11-05 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007527397A (ja) * 2003-07-01 2007-09-27 マイクロバイア インコーポレイテッド Ｃｏｘ−２及びｆａａｈ阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358145A1 (fr) * 1976-03-29 1978-02-10 Richard Sa Laboratoire M Nouveau medicament anti-inflammatoire, analgesique et antipyretique a base de (p-chlorobenzoyl-1 methyl-2 methoxy-5)-indole-3 acetate de p-acetamidophenol
GB1587070A (en) * 1977-06-02 1981-03-25 Sterwin Ag Pharmacologically-active 4-acetamidophenyl a-(2-methyl-ind(en/ol)-3-yl)-acetates processes for their preparation and pharmaceutical composition incorporating them
DE69729946T2 (de) * 1996-10-15 2005-01-20 G.D. Searle Llc Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
IL144126A0 (en) * 1999-01-07 2002-05-23 Univ Vanderbilt A method of altering the specificity of cyclooxygenase-inhibiting compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575217B2 (en) 2009-03-16 2013-11-05 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders

Also Published As

Publication number Publication date
FR2835433A1 (fr) 2003-08-08

Similar Documents

Publication Publication Date Title
AU2003261302A8 (en) Storage management bridges
AU2003226079A8 (en) Asset management platform
MA29004B1 (fr) Liants pour prions et procedes d'utilisation
DE60313106D1 (de) Zugangsverwaltung
FR2827758B1 (fr) Ancillaire pour systeme d'ostheosynthese rachidienne
FR2845052B1 (fr) Ensemble pour la liaison articulee d'un miroir retroviseur
FR2872374B1 (fr) Coffret intelligent pour l'exterieur
FR2853211B1 (fr) Crampon a glace pour l'alpinisme
AU2003302238A8 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
NO20035631D0 (no) Fremgangsmåte for vurdering av en innretnings resterende levetid
FR2844975B1 (fr) Contenant pour cosmetiques
HK1070001A1 (en) Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
IL213960A0 (en) 2-(substituted phenyl)-2-hydroxyl -ethyl carbamates
FR2837421B1 (fr) Raccord hydro-electrique pour tete d'imprimante et imprimante equipee
FR2835433B1 (fr) Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2
FR2845705B1 (fr) Procede pour renforcer les fondations d'un pylone
IL139448A0 (en) Use of apo b secretion/mtp inhibitors
FR2895239B1 (fr) Utilisation d'un antagoniste du neuropeptide y pour le soin des levres endommagees ou sensibles
FR2837285B1 (fr) Pack d'imagerie ultrasonore
FR2837708B1 (fr) Utilisation de la 8'-hydroxydihydroergotamine pour la fabrication d'un medicament contre la migraine
IL139449A0 (en) Use of apo b secretion/mtp inhibitors
FR2834519B1 (fr) Utilisation du promoteur du wdv pour une expression specifique du phloeme
FR2844445B1 (fr) Agrafe chirurgicale et ancillaire pour sa mise enplace
FR2864826B1 (fr) Plateau pour la conservation d'un repas temoin
ITFO20020024A1 (it) Perfezionamenti alle scatole d'incasso universali

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20181031